5-Cyano-2-fluorophenyl 4-benzhydrylpiperidine-1-carboxylate

ID: ALA4548730

PubChem CID: 118679371

Max Phase: Preclinical

Molecular Formula: C26H23FN2O2

Molecular Weight: 414.48

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  N#Cc1ccc(F)c(OC(=O)N2CCC(C(c3ccccc3)c3ccccc3)CC2)c1

Standard InChI:  InChI=1S/C26H23FN2O2/c27-23-12-11-19(18-28)17-24(23)31-26(30)29-15-13-22(14-16-29)25(20-7-3-1-4-8-20)21-9-5-2-6-10-21/h1-12,17,22,25H,13-16H2

Standard InChI Key:  SXVBNJWPYGQMTB-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 31 34  0  0  0  0  0  0  0  0999 V2000
   36.1125  -21.5231    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.8194  -21.9340    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.5244  -21.5277    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.5273  -20.7061    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   36.8191  -20.2923    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.1039  -20.7043    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.2401  -20.2949    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.9510  -20.7092    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   38.2419  -19.4736    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   39.6637  -20.2980    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.3734  -20.7160    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.0856  -20.3055    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.0879  -19.4833    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.3720  -19.0733    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.6626  -19.4820    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.4018  -21.9335    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.6889  -21.5268    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.4039  -22.7549    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.6890  -20.7077    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.9769  -20.2969    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.2652  -20.7115    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.2700  -21.5370    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.9826  -21.9400    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.6918  -23.1664    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.6936  -23.9870    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.4070  -24.3945    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.1201  -23.9797    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.1149  -23.1605    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.3695  -21.5373    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   40.3694  -18.2548    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.3683  -17.4334    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  6  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  4  7  1  0
  7  8  1  0
  7  9  2  0
  8 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
  1 16  1  0
 16 17  1  0
 16 18  1  0
 17 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 17  1  0
 18 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 18  1  0
 11 29  1  0
 30 31  3  0
 14 30  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA4548730

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 414.48

Molecular Weight (Monoisotopic): 414.1744

AlogP: 5.74

#Rotatable Bonds: 4

Polar Surface Area: 53.33

Molecular Species: ┄

HBA: 3

HBD: ┄

#RO5 Violations: 1

HBA (Lipinski): 4

HBD (Lipinski): ┄

#RO5 Violations (Lipinski): 1

CX Acidic pKa: ┄

CX Basic pKa: ┄

CX LogP: 5.83

CX LogD: 5.83

Aromatic Rings: 3

Heavy Atoms: 31

QED Weighted: 0.55

Np Likeness Score: -1.06

References

1. Alapafuja SO, Malamas MS, Shukla V, Zvonok A, Miller S, Daily L, Rajarshi G, Miyabe CY, Chandrashekhar H, Wood J, Tyukhtenko S, Straiker A, Makriyannis A..  (2019)  Synthesis and evaluation of potent and selective MGL inhibitors as a glaucoma treatment.,  27  (1): [PMID:30446439] [10.1016/j.bmc.2018.11.003]

Source

Source(1):

• Scientific Literature